Holen Sie sich die Stockscreener-App
112.00
0.42%
0.47
Schlusskurs vom Vortag:
$111.53
Offen:
$111.68
24-Stunden-Volumen:
225.46K
Relative Volume:
1.02
Marktkapitalisierung:
$2.56B
Einnahmen:
$249.60M
Nettoeinkommen (Verlust:
$57.73M
KGV:
44.55
EPS:
2.5139
Netto-Cashflow:
$74.47M
1W Leistung:
-0.36%
1M Leistung:
+3.24%
6M Leistung:
+29.82%
1J Leistung:
+39.23%
1-Tages-Spanne:
$109.94
$113.83
1-Wochen-Bereich:
$106.38
$113.87
52-Wochen-Spanne:
$78.35
$118.01
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Firmenname
Lemaitre Vascular Inc
Sektor
Telefon
781-221-2266
Adresse
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT vs ISRG, BDX, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
112.00 | 2.55B | 249.60M | 57.73M | 74.47M | 2.5139 |
ISRG
Intuitive Surgical Inc
|
451.38 | 160.21B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
144.17 | 41.62B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
45.32 | 37.37B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
74.45 | 35.82B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
207.88 | 30.38B | 5.40B | 1.49B | 1.78B | 10.12 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2025-02-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-02-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-10-15 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2024-08-02 | Fortgesetzt | Lake Street | Buy |
| 2024-05-31 | Fortgesetzt | ROTH MKM | Buy |
| 2024-04-26 | Hochstufung | Stifel | Hold → Buy |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-06 | Eingeleitet | Oppenheimer | Outperform |
| 2023-08-03 | Herabstufung | Jefferies | Buy → Hold |
| 2023-05-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | Eingeleitet | Jefferies | Buy |
| 2021-02-12 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | Hochstufung | Sidoti | Neutral → Buy |
| 2019-10-24 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | Hochstufung | Lake Street | Hold → Buy |
| 2019-10-14 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | Bestätigt | Barrington Research | Outperform |
| 2019-07-25 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2018-06-08 | Fortgesetzt | ROTH Capital | Buy |
| 2018-04-26 | Herabstufung | Stifel | Buy → Hold |
| 2018-04-26 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2017-10-27 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-07-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-03-21 | Eingeleitet | First Analysis Sec | Overweight |
| 2017-02-22 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-07-28 | Bestätigt | Barrington Research | Outperform |
| 2016-02-25 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten
LeMaitre outlines 2026 targets including $280M revenue and $3 EPS as international Artegraft expands - MSN
LeMaitre Vascular (NASDAQ:LMAT) Issues Earnings Results - MarketBeat
LeMaitre Vascular (LMAT) Reports 11% Q1 Sales Growth, Raises 2026 Guidance, and Declares $0.25 Dividend - Minichart
LeMaitre Vascular Q1 Earnings Call Highlights - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Reports Steady Q1 2026 Results with Earnings Beat and In-Line Revenue - ChartMill
Why LeMaitre Vascular Stock Is Sinking Today - TipRanks
Earnings call transcript: LeMaitre Vascular’s Q1 2026 results beat expectations - Investing.com
LeMaitre Vascular Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
LeMaitre Vascular (LMAT) Tops Q1 Earnings Estimates - Yahoo Finance
LeMaitre Vascular (NASDAQ:LMAT) Issues FY 2026 Earnings Guidance - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Updates Q2 2026 Earnings Guidance - MarketBeat
LeMaitre: Q1 Earnings Snapshot - kare11.com
LeMaitre (NASDAQ:LMAT) Posts Q1 CY2026 Sales In Line With Estimates - Yahoo Finance
LeMaitre Vascular (NASDAQ: LMAT) posts strong Q1 2026 results and raises 2026 growth outlook - Stock Titan
(LMAT) LeMaitre Vascular, Inc. Expects Q2 Revenue Range $70.5M$72.5M - marketscreener.com
Earnings Flash (LMAT) LeMaitre Vascular, Inc. Reports Q1 Revenue $66.6M, vs. FactSet Est of $66.7M - marketscreener.com
BRIEF-LeMaitre Vascular Q1 Sales USD 66.551 Million Vs. IBES Estimate USD 66.5 Million - TradingView
LeMaitre Q1 2026 Financial Results - ChartMill
MSN Money - MSN
LeMaitre Vascular earnings in focus: Can margin gains continue? By Investing.com - Investing.com Nigeria
LeMaitre Vascular earnings in focus: Can margin gains continue? - Investing.com UK
LeMaitre (LMAT) Q1 Earnings Report Preview: What To Look For - Yahoo Finance
(LMAT) Risk Channels and Responsive Allocation - Stock Traders Daily
How Investors May Respond To LeMaitre Vascular (LMAT) Profit Boost From Strong Operating Leverage - Yahoo Finance
Conestoga Capital Advisors LLC Trims Stock Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular, Inc. $LMAT Shares Acquired by Vest Financial LLC - MarketBeat
Comerica Bank Lowers Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular (LMAT) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Lemaitre Vascular (LMAT) is Strengthening Profitability in Vascular Disease Treatment - Insider Monkey
LeMaitre Vascular Q3 2025 Earnings Preview - MSN
New Strong Buy Stocks for November 14th - MSN
LeMaitre Vascular, Inc. $LMAT Shares Sold by Copeland Capital Management LLC - MarketBeat
Director at LeMaitre Vascular (LMAT) exercises 2,941 share options - Stock Titan
M&T Bank Corp Boosts Stake in LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular (LMAT) Stock: Market Direction Signals | Q4 2025: EPS Tops ViewsGuidance Update - Cổng thông tin điện tử Tỉnh Sơn La
LMAT (LeMaitre Vascular Inc.) posts 13.5% YoY Q4 2025 revenue growth, shares fall 2.75% despite mild EPS beat.Trending Buy Opportunities - Cổng thông tin điện tử tỉnh Tây Ninh
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Stock Crosses Above 200 Day Moving AverageTime to Sell? - MarketBeat
(LMAT) Movement as an Input in Quant Signal Sets - Stock Traders Daily
LMAT SEC FilingsLemaitre Vasculr 10-K, 10-Q, 8-K Forms - Stock Titan
Is It Too Late To Consider Buying LeMaitre Vascular (LMAT) After Its Strong Share Price Run? - Yahoo Finance
LeMaitre Vascular (LMAT) Stock: Bullish vs Bearish (+2.43%) 2026-04-18Volatility Breakout - Cổng thông tin điện tử tỉnh Tây Ninh
LMAT Stock Price, Quote & Chart | LEMAITRE VASCULAR INC (NASDAQ:LMAT) - ChartMill
Surgical Equipment & ConsumablesSpecialty Stocks Q4 Earnings: LeMaitre (NASDAQ:LMAT) Firing on All Cylinders - Yahoo Finance
LEMAITRE VASCULAR INC ($LMAT) CEO 2025 Pay Revealed - Quiver Quantitative
LeMaitre Vascular (NASDAQ:LMAT) Upgraded to "Strong-Buy" at Zacks Research - MarketBeat
Annex Advisory Services LLC Acquires 13,692 Shares of LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026 - The Manila Times
LMAT | LeMaitre Vascular, Inc. FinancialsIncome Statement - Quiver Quantitative
LeMaitre Vascular, Inc. to Announce First Quarter 2026 Financial Results on May 5, 2026 - Quiver Quantitative
Finanzdaten der Lemaitre Vascular Inc-Aktie (LMAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.78%
0.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):